Multi-disciplinary Symposium on “Advanced Technologies in Gynaecologic Oncology” – Opening remarks by Dr. David Tan. A multi-disciplinary symposium on “Advanced Technologies in Gynaecologic Oncology” was held on 4th April 2018 at the Suntec City Convention and Exhibition Centre, Singapore. The full-day programme was organized by Dr David Tan from Asian American Radiation & Oncology and Dr John Chia from Oncocare Women’s Cancer Clinic. Prominent local and regional experts as well as guests from the MD Anderson Cancer Centre and the Royal Marsden Hospital were invited to speak at the conference, which was in turn attended by specialists from multiple disciplines including pathologists, gynaecologists, radiation and medical oncologists, radiologists and surgical oncologists. Members from the allied health community including nurses, radiation therapists, dosimetrists and laboratory specialists also attended the conference. Topics that were covered include oncogenetics and its role in cancer screening, diagnosis and treatment of gynaecological cancers, advanced radiotherapy and surgical techniques, latest chemotherapy and targeted agents, and updates from the latest scientific trials. An interesting primer on the emerging role of AI in histopathology and diagnostic radiology in cancer management was also covered. This symposium served to provide a timely update of the latest scientific and technological advances in the management of gynaecological cancers. It was also an opportunity to bring the local and regional gynae-oncology community together to encourage inter-disciplinary discussion, thus improving standards of care for our patients.

Conference session: “Will molecular Human Papilloma Virus screening replace Pap smears?” by Dr Lisa Wong, Consultant Gynaecological Oncologist at Lisa Wong Women & Gynae Oncology Centre, Mount Elizabeth Medical Centre, Singapore

Conference session: “Advanced radiotherapy technologies in the management of cervical cancers” by Professor Anuja Jhingran, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Conference Session: “Ovarian cancer genomics – A revolution in treatment and screening?” by Dr Angela George, Consultant in Oncogenetics, The Royal Marsden NHS Foundation Trust, London, UK